Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies
Dermatol Reports
.
2023 Jun 19;16(1):9755.
doi: 10.4081/dr.2023.9755.
eCollection 2024 Mar 12.
Authors
Edoardo Mortato
1
,
Silvia Baratta
1
,
Luca Rubino
1
,
Anna Paola De Caro
1
,
Francesco Loconsole
1
Affiliation
1
Clinica Dermatologica Azienda Ospedaliera Universitaria Policlinico Consorziale Bari, Italy.
PMID:
38623361
PMCID:
PMC11017720
DOI:
10.4081/dr.2023.9755
No abstract available
Keywords:
antirheumatic agents; biological therapy; costs and cost analysis; psoriasis.
Grants and funding
Funding: none.